Genentech: Cyrus Khojasteh | Senior Director and Senior Principal Scientist (Technology), Drug Metabolism & Pharmacokinetics

Scientists / Our Scientists

"My ability to contribute to the discovery of safe and efficacious drugs to treat important unmet medical conditions is what keeps me inspired."

Years at Genentech

Publications at Genentech

Awards & Honors

I joined Genentech in 2000 and had the opportunity to contribute in building the state-of-the-art organization that supports small molecule and antibody-drug conjugates in both discovery and development. I work with a very talented team of scientists that are passionate about discovering the next great medicine. This is a great place where great scientists ask fundamental questions and go to the lab to test their hypothesis.

Featured Publication

A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery.

Journal of Computer-Aided Molecular Design 2015, 29(4): 327-38.

Aliagas I, Gobbi A, Heffron T, Lee ML, Ortwine DF, Zak M, Khojasteh SC.

View Abstract

My research focus is to figure out the molecular mechanism for metabolism. How and where does a drug candidate is converted to metabolite(s). This is not only focused on cytochrome P450 enzymes, which are very important, but also to all kinds of enzyme systems that are involved in oxidation, reduction, hydrolysis and conjugation. I am also interested in soft spots in the drug candidates and how the molecule could be changed to minimize metabolic rates. I am also interested in the consequence of metabolism, with asking if we are making reactive metabolites that can covalently modify cellular macromolecules.

An Integrated Strategy for Assessing the Metabolic Stability and Biotransformation of Macrocyclic Peptides in Drug Discovery toward Oral Delivery

Analytical Chemistry, ISSN: 15206882 00032700

Yukuang Guo; Shaofei Ji; Wei Wang; Susan Wong; Chun-Wan Yen; Chloe Hu; Dennis H. Leung; Emile G. Plise; Shu Zhang; Chenghong Zhang; Uchenna A. Anene; Donglu Zhang; Christian N. Cunningham; S. Cyrus Khojasteh; Dian Su

Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported.

We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Cyrus Khojasteh

Senior Director and Senior Principal Scientist (Technology), Drug Metabolism & Pharmacokinetics

Featured Publication

A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery.